Dr. Alexander Epelbaum

Dr. Alexander Epelbaum
Alexander Epelbaum, MD received his Bachelor of Arts degree, cum laude, from New York University. He went on to earn his medical degree from New York University School of Medicine. He completed his surgical internship and urology residency at SUNY Downstate, where he also served as Chief Resident. As a part of his training he completed an Acting Fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Epelbaum has written articles in peer review journals, and presented his research at the American Urological Association meeting, American Society of Reproductive Medicine meeting, The New York Academy of Medicine, and SUNY Downstate Annual Research Day. As is a recipient of many honors, including awards of dedication and appreciation from the Department of Veteran Affairs and Kings County Hospital Center, he has been recognized for outstanding clinical performance by Memorial Sloan Kettering Cancer Institute. Dr. Epelbaum is a Diplomate of the American Board of Urology and a Fellow of the American College of Surgeons. He is an active member of the American Urological Association. In addition, Dr. Epelbaum is the President of the medical staff at St. Catherine of Siena Medical Center. Dr. Epelbaum practices adult urology and his special interests include minimally invasive surgery, female incontinence, kidney stone disease, laparoscopic surgery, and urologic malignancies.
Medical School:

NYU School of Medicine

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only